ZA200205746B - Method for producing aryl-iminomethyl-carbamic acid esters. - Google Patents

Method for producing aryl-iminomethyl-carbamic acid esters. Download PDF

Info

Publication number
ZA200205746B
ZA200205746B ZA200205746A ZA200205746A ZA200205746B ZA 200205746 B ZA200205746 B ZA 200205746B ZA 200205746 A ZA200205746 A ZA 200205746A ZA 200205746 A ZA200205746 A ZA 200205746A ZA 200205746 B ZA200205746 B ZA 200205746B
Authority
ZA
South Africa
Prior art keywords
formula
compound
denotes
phenyl
hydroxy
Prior art date
Application number
ZA200205746A
Inventor
Joerg Brandenburg
Rainer Soyka
Rolf Schmid
Ralf Andderskewitz
Rolf Bauer
Rainer Hamm
Jutta Kroeber
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Publication of ZA200205746B publication Critical patent/ZA200205746B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C269/00—Preparation of derivatives of carbamic acid, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/20—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by nitrogen atoms not being part of nitro or nitroso groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/62—Compounds containing any of the groups, X being a hetero atom, Y being any atom, e.g. N-acylcarbamates
    • C07C271/64—Y being a hydrogen or a carbon atom, e.g. benzoylcarbamates

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Indole Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Description

® ; Fos “ Ls FR Le r : 72286pct.206
Process for preparing aryl-iminomethyl-carbamino acid esters
The invention relates to a process which can be used on an industrial scale for the production of compounds of general formula (1) 0 yo oR? ach (H wherein the groups R1 and R2 may have the meanings given in the specification and claims.
Background of the invention
From International Patent Application WO 96/02497, benzamidines and aryl- __ __ ___ _iminomethylcarbamino acid esters are known which are highly effective as. NEU pharmaceutical compositions with an LTB4-antagonistic activity. Compounds of ~ general formula (1) are of particular importance.
The problem of the present invention is to provide a process which can be used for industrial-scale synthesis of compounds of general formula(l) in high yields and with end products of high purity.
Detailed description of the invention
To solve the problem mentioned above, the invention proposes a process for preparing compounds of general formula (1) 0
Nor
SING a
Or ( wherein
R1 denotes a group selected from among methyl, ethyl, propyl, cyclopentyl, cyclohexyl, phenyl, benzyl and -C(Mep)phenyl, each of which may be mono-, di- or trisubstituted by hydroxy;
RZ denotes a group selected from among methyl, ethyl, propyl and benzyl,
characterised in that a compound of general formula (ll)
CN
EL Ir ave (1) wherein
R1" denotes a group selected from among methyl, ethyl, propyl, cyclopentyl, cyclohexyl, phenyl, benzyl and -C(Meo)phenyl, each of which may be mono-, di- or trisubstituted by a group -O-PG, the group -O-PG denoting a protected hydroxyl function selected from among methoxymethyloxy, 2- methoxyethoxymethyloxy, 1-ethoxyethyloxy, 2-tetrahydropyranyloxy , 1- butoxyethyloxy, tert.-butyloxy, benzyloxy and 4-methoxybenzyloxy, is first reacted in an ethereal or aromatic solvent with an alkali metal ..~ -- - hexaalkyldisilazane-and is then treated with a compound of formula-(Hi)- - Cee
R2-0-COX' (lll) wherein
R2 js as hereinbefore defined and
X denotes chlorine, bromine or -O-RZ, after working up using an acid of formula HY a compound of formula (IV) 0
HN SOR?
RE or NH x HY
ACA
(iV) wherein the groups R1 and R2 are as hereinbefore defined and Y denotes any desired acid group, is isolated and from this the compound of formula (1) is liberated.
The compounds of formulae (I) and (IV) also include the corresponding tautomers of formulae (I-T) and (IV-T):
his
HN” “OR?
Aca (I-T) x
N OR? (re (IV-T)
The term “alkali metal hexaalkyldisilazane” as used above and hereinafter to denote the reagent which is reacted with the compound of formula (II) generally designates ~~ 7 77 acompound of formula (viy ~~~ oo EE
R\ . 3
SIC
Met* N, Co (VI) 3_-Si—R
R77
R wherein
Met denotes an alkali metal, preferably lithium, sodium or potassium, particularly lithium, and
R® independently in each case denotes a C,-alkyl group, preferably methyl or ethyl, especially methyl.
Most particularly preferred are lithium hexamethyldisilazane, sodium hexamethyldisilazane and potassium hexamethyldisilazane, particularly lithium hexamethyldisilazane. -
The term “subsequent reaction” with a compound of formula (Ill) covers both procedures in which the product of the reaction of the compound of formula (I) with the alkali metal hexamethyldisilazane is reacted with the compound of formula (iil) directly, without any further intermediate reaction, and also procedures in which the free amidine base is liberated in the mean time from the product formed. Preferably,
® the product of the reaction of the compound of formula (Il) with the alkali metal hexamethyldisilazane is reacted with the compound of formula (lll) directly, especially in a “one-pot synthesis”.
A preferred process for preparing compounds of general formula (1) is one wherein
R1 denotes a group selected from among phenyl, benzyl and -C(Me3)phenyl, each of which may be mono- or disubstituted, preferably monosubstituted by hydroxy;
R2 denotes a group selected from among ethyl, propyl and benzyl, characterised in that a compound of general formula (ll) wherein
R1" denotes a group selected from among phenyl, benzyl and -C(Me2)phenyl, each of which may be mono- or disubstituted, preferably monosubstituted by a group -O-PG, the group -O-PG denoting a protected hydroxyl function selected from among methoxymethyloxy, 2-methoxyethoxymethyloxy, 1- ethoxyethyloxy, 2-tetrahydropyranyloxy , 1-butoxyethyloxy, tert.-butyloxy, =o == = = ~penzyloxy and 4-methoxybenzyloxy, preferably 2-tetrahydropyranyloxy, ~~ is first reacted in an ethereal or aromatic solvent with an alkali metal hexaalkyldisilazane and then treated with a compound of formula (lll)
R2-0-COX" (ll) wherein
R2 is as hereinbefore defined and
X denotes chlorine, bromine or -O-R2, after working up with aqueous hydrochloric acid a compound of formula (IVA) 0
HN SOR?
RE jen x HCI
Acs (IVA) wherein the groups R1 and RZ are as hereinbefore defined is isolated and from this the compound of formula (l) is liberated.
Particularly preferred is a process for preparing compounds of general formula (I) wherein
R1 denotes -C(Mep)phenyl which may optionally be monosubstituted by hydroxy and
RZ denotes ethyl, characterised in that a compound of general formula (Il) 5 wherein
R1" denotes -C(Me2)phenyl, which may optionally be monosubstituted by a group -0-PG, the group -O-PG denoting a protected hydroxyl function selected from among methoxymethyloxy, 2-tetrahydropyranyloxy , 1-butoxyethyloxy, tert.-butyloxy, benzyloxy and 4-methoxybenzyloxy, preferably 2-tetrahydropyranyloxy, is first reacted in an ethereal or aromatic solvent with an alkali metal hexaalkyldisilazane and then treated with a compound of formula (lil)
R2-0-COX' (lll) wherein
R2 is as hereinbefore defined and
X denotes chlorine, bromine or -O-R2, preferably chlorine, ~~ - after working up with aqueous hydrochloric acid a compound of formula (IVA) Co wherein the groups R1 and R2 are as hereinbefore defined is isolated and from this the compound of formula (I) is liberated.
In a particularly preferred embodiment of the process according to the invention, the compound of formula (11) is prepared in a process comprising the following steps: (@) reacting C,4-alkkyl 3-halomethylbenzoates with 4-hydroxybenzonitrile in the manner of a Wilkinson ether synthesis; (b) reductively converting the resulting alkyl 3-(4-cyano-phenoxy)benzoates of formula (VII)
SON
SOR: (Vi) wherein R’ denotes C,,-alkyl, into a compound of formula (V) g CN (V)
® 3 wherein X denotes hydroxy; (c) optionally treating the compound of formula (V) wherein X denotes hydroxy with a halogenating reagent or a sulphonic acid chloride; (d) reacting the compound of formula (V) wherein X denotes hydroxy, chlorine, bromine, mesylate, triflate or tosylate, with a phenol derivative of formula (VI) “CL wherein R1' has the meanings given in claims 1 to 4; optionally in the form of the corresponding sodium or potassium phenoxides, under basic reaction conditions, preferably in a polar organic solvent.
The hydrochlorides of formula (IVA) are of central importance in the process a 15 according to the invention for preparing the compounds of general formula (1). They- - - are obtained directly in high yields as readily crystallising salts, from which by- products and/or impurities can easily be removed by crystallisation. Accordingly, one aspect of the present invention relates to intermediate products of general formula (IVA) x
HN” “OR?
E on x HCI (re (IVA) wherein the groups R1 and R2 may be as hereinbefore defined.
Of the compounds of general formula (IVA) the compound ethyl {[4-(3-{4-[1-(4- hydroxy-phenyl)-1-methyl-ethyl]-phenoxymethyl}-benzyloxy)-phenyl]-imino-methyl}- carbaminate hydrochloride is particularly preferred.
The compounds of general formula (II)
CN
LLL cr
Ash (in wherein R1 may be as hereinbefore defined are obtained according to the invention by reacting a compound of formula (V)
® , ol “(Je (V) wherein X denotes hydroxy, chlorine, bromine, mesylate, triflate, benzenesulphonate or tosylate, with a compound of formula (VI)
CL wherein R1 may be as hereinbefore defined and wherein the compound of formula (VI) may optionally also be used in the form of the sodium and potassium phenoxides thereof, under basic reaction conditions in a polar organic solvent.
It is preferred to prepare compounds of general formula (Il) wherein RT may be as hereinbefore defined by reacting a compound of formula (V) wherein X denotes hydroxy, chlorine or mesylate, more preferably hydroxy or chlorine, most preferably chlorine, with a compound of formula (VI) wherein R1 may be as hereinbefore ~~ defined and wherein the compound of formula (V1) is used in the form of the alkali metal phenoxides thereof, preferably in the form of the sodium phenoxides thereof.
When the compounds of general formula (I) are synthesised according to the invention, the intermediate products of general formula (V) are of central importance.
In another aspect, therefore, the present invention relates to the compounds of general formula (V) or
Vv) as such, wherein X may be as hereinbefore defined and most preferably may denote hydroxy or chlorine.
The compound of formula (V1), one of the starting compounds, is also of particular importance in the synthesis according to the invention of the compounds of general formula (1). Therefore, in another aspect, the present invention relates to the compounds of formula (VII)
SAO: (VI)
@® as such, wherein R' denotes C4-4-alkyl, preferably methyl or ethyl, most preferably methyl.
In order to perform the process for preparing the compounds of general formula (1) according to the invention starting from the nitriles of general formula (Il) the following method is used:
A compound of general formula (11) is slowly metered into a solution of the alkali metal hexaalkyldisilazane, preferably lithium bis(trimethylsilyl)-amide, sodium bis(trimethylsilyl}-amide, most preferably lithium bis(trimethylsilyl)-amide, in an ethereal or aromatic organic solvent, preferably in a solvent selected from among tetrahydrofuran, toluene, dioxane, more preferably in tetrahydrofuran or dioxane, most preferably in tetrahydrofuran, preferably with cooling, especially at a temperature between -50°C and 30°C, more especially at -20°C to 10°C, most especially at about 0°C. The quantity of the alkali metal hexaalkyldisilazane used is determined by the amount of nitrile of formula (II) used. Atleast 1 mol, preferably © 1.01 to 1.15 mol of alkali metal hexaalkyldisilazane is used per mol of nitrile of formula (ll). The quantity of ethereal solvent used is between 0.7 and 1.5, preferably 0.9 to 1.3 kg per mol of compound of formula (ll) used.
After all the compound of formula (Il) has been added the resulting suspension is stirred at constant temperature, optionally at a temperature of up to 40°C, preferably ‘at about 20-25°C over a period of 6 to 24 hours, preferably 8 to 18 hours. The stirring is preferably continued for 10 to 12 hours. During this time the solid which was initially in suspension may go into solution.
The mixture can then optionally be diluted either with additional ethereal solvent or with a nonpolar organic solvent, preferably with an aromatic organic solvent. A solvent selected from among toluene, benzene, cyclohexane, methylcyclohexane or xylene is preferably used, of which toluene and xylene are particularly preferred, toluene being most preferred. If the mixture is diluted, it is sufficient to add up to 0.5
L, preferably up to 0.3 L of solvent per mol of compound of formula (ll) used.
The reaction mixture is heated to a reaction temperature of between -50°C and 20°C, more especially -20°C to 10°C, most preferably -10 to 0°C before the addition of the compound of general formula (lll). Then the compound of formula (11) is added, in an amount of at least 1 mol, preferably 1.05 to 1.3 mol, more particularly 1.1 to 1.2 mol, per mol of compound (I) used.
_
After the reaction is complete, the product is hydrolysed by the addition of an acid of formula HX, preferably an inorganic or organic acid such as hydrochloric acid, sulphuric acid, phosphoric acid, acetic acid, trifluoroacetic acid, oxalic acid and fumaric acid, particularly aqueous hydrochloric acid. About 1 mol of acid, particularly hydrochloric acid, is used per mol of the compound of formula (ll) originally used. According to the invention, it is preferable to add dilute hydrochloric acid (preferably 8-15%, more especially 10-12% strength).
After a period of about 10 minutes to 1 hour the aqueous lower phase is separated off and an organic solvent selected from among acetone, methylisobutylketone, methylethylketone, optionally a mixture of two of the above solvents, most preferably a mixture of acetone and methylisobutylketone in a ratio of 3-1 : 1, most preferably in a ratio of 2.5-1.5 : 1, is added to the organic phase. Crystallisation of the compounds of formula (IVA) is initiated by the addition of aqueous hydrochloric acid. About 1 to 1.2 mol of hydrochloric acid is used per mole of the compound of formula (Il) originally used. lt is preferred according to the invention to add preferably 32-37%, most preferably 37% hydrochloric acid. The compounds of formula (IV) are - = = separated from the reaction mixture by conventional methods, e.g. by centrifugation, washed with an organic solvent selected from among acetone, methylisobutylketone, methylethylketone ora carboxylic acid ester, preferably acetone, and dried.
The release of the compounds of formula (I) from the acid addition salts of formula (IV), particularly from the hydrochlorides of formula (IVA), is generally carried out with basic reactants under reaction conditions which are as neutral as possible, preferably in the presence of buffer systems, according to the method described hereinafter:
An organic solvent selected from among acetone, methylisobutylketone, methylethylketone, tetrahydrofuran or a carboxylic acid ester, preferably acetone, and then a compound of formula (IV) are added to a solution of trisodium citrate dihydrate, sodium hydroxide, potassium hydroxide, alkali or alkaline earth metal salts of organic or inorganic weak acids, preferably trisodium citrate dihydrate, trisodium citrate or sodium hydroxide, most preferably trisodium citrate dihydrate in water at O- 40°C, preferably at 20-25°C, particularly at about 20°C. About 1-2 mol, preferably about 1.5 mol of the sodium or potassium citrate used and about 1 to 3 L of the abovementioned organic solvent, preferably about 2 L, are used per mol of compound of formula (IV) put in. The mixture is stirred at constant temperature over a period of 20 minutes to 2 hours, preferably 1-1.2 hours.
®
When strong bases such as sodium hydroxide are used, the method of addition may be reversed if desired. The crystalline product is separated off by filtration, for example, washed with water to remove any salt, and with the abovementioned organic solvent and finally dried.
The compounds of general formula (Il) may be obtained by reacting a compound of formula (V) with a compound of formula (VI), as already mentioned. According to the invention, the following procedure may be used.
The compound of formula (V) wherein X denotes hydroxy is dissolved in an organic solvent, if possible an aprotic-polar organic solvent, preferably N,N- dimethylacetamide, acetone, methylethylketone, methylisobutylketone, N- methylpyrrolidone, N,N-dimethylformamide, tetraalkylurea, most preferably in N,N- dimethylacetamide. 0.5 to 1.0, preferably about 0.7 L of solvent are used at this point per mol of starting compound according to the invention. Then the solution thus obtained is cooled to a temperature of <10°C, preferably to a temperature between +5°C and -20°C, most preferably to about -10°C to 0°C. Then a suitably substituted ~~~ sulphonic acid chloride, optionally the abovementioned organic solvent, an organic ~~ base, optionally the abovementioned organic solvent and the aqueous solution of an inorganic base are added one after the other. A suitably substituted sulphonic acid chloride according to the invention might be methanesuiphonic acid chloride, para- toluenesulphonic acid chloride, benzenesulphonic acid chloride or trifluoromethanesulphonic acid chloride. Preferably, methanesulphonic acid chloride is used. The organic bases may be, for example, dimethylaminopyridine, pyridine, methylpyridine, tert. amines, e.g. trimethylamine, triethylamine, diisopropylethylamine, or cyclic amines such as N-methylpyrrolidine or DBU (diazabicycloundecene). Preferred organic amines are N-methyipyrrolidine, trimethylamine, triethylamine or diisopropylethylamine, most preferably triethylamine.
The organic base is used in at least a stoichiometric amount, based on the starting compound of formula (V). Preferably, the organic base is used in an excess of 10-50 mol%, most preferably in about a 30% excess in relation to the compound of formula (V) used. The aqueous solution of an organic base used will usually be an alkali metal or alkaline earth metal hydroxide solution, the alkali metal hydroxide solutions being preferred. The aqueous solutions of potassium hydroxide and sodium hydroxide are particularly important according to the invention. Usually, 20-50% solutions of the abovementioned inorganic hydroxides are used. More concentrated solutions such as, for example, 45% solutions are preferred according to the invention. Based on the compound of formula (V) used, the inorganic base is used in at least a stoichiometric amount, preferably in an excess of 50-100 mol%. The
® inorganic base is particularly preferably used in an excess of about 75 mol% , based on the compound of formula (V) added.
If desired, the reaction mixture may be diluted after the addition of the suitably substituted sulphonic acid chloride or the organic base by the addition of the abovementioned organic solvent. In this case, 2-10%, preferably about 5% of the quantity of solvent put in initially is added.
In any case, after all the aqueous solution of the inorganic base has been added, the reaction mixture is diluted with the organic solvent mentioned above. About 0.5 to 1.0 L, preferably between 0.7 and 0.8 L of the solvent used are added, per mol of starting compound of formula (V) used. Then alkoxides or metal salts of formula (Vi) are added. The sodium and potassium phenoxides which may be derived from the compounds of formula (V1) are preferably used. According to the invention, stoichiometric quantities, optionally substoichiometric quantities or an excess of the compound (VI) may be added, based on the educt of formula (V). After all the compound (VI) has been added, the reaction is continued for a period of about 1-3 ~~~ hours, preferably about 1.5 to 2 hours at a temperature of 5-35°C, preferablyat =~ ~~ about 25°C, and finally stirred for a period of about 1-3 hours, preferably about 1.5-2 hours at a temperature of 50-100°C, preferably at about 70-90°C. After the reaction has ended the product of formula (il) is crystallised by the addition of a suitable polar solvent selected from among the lower alcohols and water.
In order to obtain high yields of particularly pure products, it has proved preferable according to the invention to add, for the crystallisation, a solvent mixture consisting of a nonpolar organic solvent, preferably xylene or toluene, most preferably toluene, a polar organic solvent, preferably a lower alcohol such as methanol, ethanol , butanol or isopropanol, especially isopropanol and water. The ratio by volume of nonpolar to polar organic solvent to water can vary within the range from 1:7 -10: 5 - 8, preferably 1: 8-9: 6 - 7. By cooling to below 50°C, preferably to about 30°C, the crystallisation of the product of formula (Il) is completed. After isolation, the crystallised product is optionally washed with the abovementioned lower alcohol and with water.
If the compounds of formula (il) are to be obtained from the compounds of formula (V) wherein X has a meaning other than hydroxy, the following procedure may be used according to the invention.
The sodium or potassium phenoxide derived from the compounds of formula (V1) is taken up in water together with a compound of formula (V), mixed with a nonpolar organic solvent and optionally reacted under phase transfer conditions. The phase
Qo transfer catalysts which may be used according to the invention include the quaternary ammonium salts, preferably the halides, sulphates or hydroxides of tetradecyltrimethylammonium, hexadecyltrimethylammonium, tetrabutylammonium, tributylmethylammonium or triethylbenzylammonium . The nonpolar organic solvent may be a chlorinated hydrocarbon such as methylene chloride or preferably, according to the invention, an aromatic hydrocarbon such as benzene, toluene, xylene, preferably toluene. The compounds of formula (V) and (VI) are used in a virtually stoichiometric ratio, and if desired one of the two reactants may also be used in a slight excess (e.g. 15%). The amount of solvent to be used depends on the quantity of educt put in. Between 1 and 2 L of water and between 0.3 and 1.0 L of the organic solvent, preferably between 1.5 and 1.8 L of water and 0.5t0 0.7 L of the organic solvent are used per mol of compound of formula (VI) putin.
The reaction is carried out with intensive stirring over a period of 3 to 9, preferably 5 to 7 hours at a temperature of 50 to100°C, preferably at 70 to 80°C. Then, to crystallise the product, a polar organic solvent, preferably a lower alcohol, most preferably isopropanol is added to the separated organic phase. By cooling to below - = = 50°C, preferably to about 30°C, the crystallisation of the product of formula (Il)is ~~ completed. After being isolated, the crystallised product of formula (ll) is optionally washed with the abovementioned lower alcohol and with water.
The starting compounds of formula (V)
CN
“OO or
V) which, as already mentioned, relate to one aspect of the present invention, may be prepared analogously to methods of synthesis known per se. The compound of formula (V) wherein X denotes hydroxy may be prepared by reacting methyl 3- halomethyl-benzoates with 4-hydroxybenzonitrile, for example, in a Wilkinson ether synthesis. The methyl 3-(4-cyano-phenoxy)-benzoate (VII) thus obtained can be reductively converted into the compound of general formula (V) wherein X = hydroxy (= 4-(3-hydroxymethyl-benzyloxy)-benzonitrile) by the analogous use of current standard procedures.
The compounds of formula (V) wherein X denotes chlorine or bromine may be prepared analogously to methods of synthesis known per se from the compound of formula (V) wherein X denotes hydroxy, using common halogenation reagents such as, for example, thionylchloride, phosphorus oxychloride or phosphorus pentachloride, methanesulphonic acid chloride, benzenesulphochloride, preferably thionylchloride or methanesulphonic acid chloride.
The compounds of formula (V) wherein X denotes mesylate, triflate or tosylate may be prepared analogously to methods of synthesis known per se from the compound of formula (V) wherein X denotes hydroxy, by reacting with the appropriate sulphonic acid chlorides in aprotic, preferably polar organic solvents, preferably selected from among dichloromethane, N,N-dimethylacetamide, dimethylformamide, acetonitrile,
N-methylpyrrolidone, tetraalkylurea in the presence of organic bases, preferably selected from among dimethylaminopyridine, pyridine, methylpyridine, N- methylpyrrolidine, trimethylamine, triethylamine, diisopropylethylamine and DBU (diazabicycloundecene).
The following Examples serve to illustrate methods of synthesis according to the invention, carried out by way of example, for preparing the compound of formula (1).
They must be considered as possible methods given by way of example, without restricting the invention to their content.
Example 1: Methyl 3-(4-cyano-phenoxymethyl)-benzoate: 10.00 kg (43.6mol) of methyl 3-(bromomethyl)benzoate and 5.21 kg (43.74mol) of 4- hydroxybenzonitrile are dissolved in 100 litres of acetone and stirred with 8.4 kg (60.7mol) of potassium carbonate in the presence of 0.1 kg of sodium iodide for about 4 h under reflux conditions. Then 35 litres of acetone are distilled off and 100 litres of water are added at reflux conditions. The reaction mixture is cooled to 20°C and the crystallisation is completed by the addition of another 30 litres of water. The crystals formed are separated off, washed with 50 litres of water and dried in vacuo.
Yield: 11.1 kg (95%) of methyl 3-(4-cyano-phenoxymethyl)-benzoate;
Melting point 109...112°C, white solid,
TLC (silica gel 60 F254 —ready-made plate (Merck): Rf=0.5 (toluene : acetone=9:1)
Example 2: 4-(3-hydroxymethyl-benzyloxy)-benzonitrile: 20.05 kg (26.7 mol) of methyl 3-(4-cyano-phenoxymethyl)-benzoate are dissolved in 100 litres of THF and 40 litres of methanol. At 40 to 45°C, 8.51 kg of sodium boranate are added in batches. The reaction is completed by stirring the reaction mixture at 61 to 63 °C for about 5 hours. The reaction mixture is then cooled to 25°C and 90 litres of a 15% sodium hydroxide solution are added. After stirring, the aqueous supernatant is separated off and mixed with 30 litres of a 22.5% sodium hydroxide solution. After stirring, the aqueous supernatant is separated off and from this about 100 litres of solvent are distilled off at a sump temperature of 63 to 75 °C.
®
The distillation residue is crystallised by the addition of 20 litres of isopropanol at 50 to 60°C and 150 litres of water at 40 to 50°C. After the suspension has been cooled to 20 to 30 °C the crystals are separated off, washed with 60 to 100 litres of water and batchwise with 25 litres of cold isopropanol and dried in vacuo.
Yield: 15.8 kg (88%) of 4-(3-hydroxymethyl-benzyloxy)-benzonitrile;
Melting point (DSC): 110-115°C, white solid
IR: 3444 /cm (OH band); 2229 /cm (CN band)
Example 3: 4-(3-Chloromethyl-benzyloxy)-benzonitrile:
Variant A: 7.18 g (30 mmol) of 4-(3-hydroxymethyl-benzyloxy)-benzonitrile are dissolved in 80 ml of dichloromethane, mixed with 4.13g (35 mmol) of thionylchloride and 0.1g of
DMF and stirred while heating to 40°C until the development of gas has ceased.
After cooling, the organic reaction mixture is washed successively with water and dilute sodium hydroxide solution and crystallised by evaporation.
Yield: 6.8g (88%) of 4-(3-chloromethyl-benzyloxy)-benzonitrile; So 777 TLC (silica gel 60 F254 —ready-made plate (Merck): Rf = 0.9 (toluene-acetone = 9:1),
Rf = 0.44 (toluene)
Variant B: 7.18 g (30 mmol) of 4-(3-hydroxymethyl-benzyloxy)-benzonitrile are dissolved in 22 ml of N,N-dimethylacetamide, mixed with 4.47g (39 mmol) of methanesulphonic acid chloride and 3.95g (39mmol) of triethylamine and stirred for 10 hours at 20-30°C.
Then the triethylammonium chloride precipitated is filtered off, the filtrate is mixed with 30ml of isopropanol and the desired 4-(3-chloromethyl-benzyloxy)-benzonitrile is crystallised by the metered addition of 30 ml of water. The suspension is stirred for 15 min at 10°C and filtered. The crystals are washed with a mixture of 5 ml of isopropanol and 20 ml water and dried at 20°C in vacuo.
Yield: 6.8g (88%) of 4-(3-chloromethyl-benzyloxy)-benzonitrile
Melting point: 65-68°C
Example 4: Sodium-4-{1-methyl-1-{4-tetrahydro-pyran-2-yloxy)-phenyl]-ethyl}- phenoxide 121.8 kg of bisphenol A are suspended in 480 | of toluene and 46 | of THF. After the addition of the catalyst (1.3 kg of 37% hydrochloric acid) , 44.9 kg of 3,4-dihydro- 2H-pyran are metered in so as not to exceed a temperature of 40°C. The solid then goes into solution. Then the reaction mixture is mixed with 26. 4 kg of 45% sodium
® hydroxide solution and 260 | of water. The organic upper phase is separated off and about 50 | of solvent are eliminated by distillation. At 30 to 40°C the organic phase is washed several times with dilute sodium hydroxide solution so that sufficient purity can be achieved (monitored by TLC). If the aqueous lower phase is in the pH range 11.8to 12.2, excess bisphenol A can easily be separated off.
The toluene phase purified by extraction is mixed with 11 litres of isopropanol and 80 litres of water and heated to 50 to 55 °C. By the addition of 47.4 kg of 45% sodium hydroxide solution and cooling the reaction mixture to 20 to 25°C, a crystal suspension is obtained. The crystals are separated by filtration, washed with about 160 1 of toluene and then dried in vacuo.
Yield: 96.5 kg (54%) (as the tetra-hydrate)
Example 5: Synthesis of 4-[3-(4-{1-methyl-1-[4-(tetrahydro-pyran-2-yloxy)-phenyl]- ethyl}-phenoxymethyl)-benzyloxy]-benzonitrile:
Variant A: (starting from Example 2) ~~ — ~~ 28Kkg (244 mol) of methanesulphonic acid chloride , 6 litres of N,N- I dimethylacetamide, 24.7 kg (244 mol) of triethylamine, 6 litres of N,N- dimethylacetamide, 29.4 kg of 45% sodium hydroxide solution, 143 litres of N,N- dimethylacetamide, 59.7 kg (178.5 mol) of Example 4 (= sodium-4-{1-methyl-1-[4- tetrahydro-pyran-2-yloxy)-phenyl]-ethyl}-phenoxide, as the tetrahydrate) are metered successively into a solution of 45 kg (188mal) of 4-(3-hydroxymethyl-benzyloxy)- benzonitrile (Example 2) in 133 litres of N,N-dimethylacetamide at about -10°to 0°C.
Then the reaction mixture is stirred for 2 h at 25°C and for another 1.5 hat 75 to 80°C. After the addition of 32 litres of toluene, 255 litres of isopropanol and 200 litres of water crystallisation begins which is completed by cooling to 30°C. The crystalline product is separated off by filtration, washed with isopropanol and water and then dried in vacuo. Yield: 85 kg (90%) of 4-[3-(4-{1-methyl-1-[4-(tetrahydro- pyran-2-yloxy)-phenyl]-ethyl}-phenoxymethyl)-benzyloxy]-benzonitrile;
Variant B: (starting from Example 3) 19.4 kg (50 mol) of Example 4 (= sodium-4-{1-methyi-1-[4-tetrahydro-pyran-2-yloxy)- phenyl]-ethyl}-phenoxide, as the tetrahydrate) and 12.2 kg (47.5 mol) of Example 3 (= 4-(3-chloromethyl-benzyloxy)-benzonitrile) are mixed with 85 litres of water, a phase transfer catalyst (e.g.: 2.1 kg (2.5 mol) of a 40% aqueous solution of tetradecyltrimethylammonium bromide and 32 litres of toluene and intensively stirred for 6 h at about 80°C. Then 44 litres of isopropanol are metered into the separated organic upper phase, at 50 to 70°C, the crystal suspension obtained is cooled to
® 16 about 25°C and filtered. The crystals separated off are washed twice with 25 litres of cold isopropanol and dried in vacuo.
Yield: 22.8 kg (90%) of 4-[3-(4-{1-methyl-1-[4-(tetrahydro-pyran-2-yloxy)-phenyl]- ethyl}-phenoxymethyl)-benzyloxy]-benzonitrile;
Example 6: Ethyl {[4-(3-{4-[1-(4-hydroxy-phenyl)-1-methyl-ethyl]-phenoxymethyl}- benzyloxy)-phenyl]-iming-methyl}-carbaminate hydrochloride 132 kg (247 mol) of 4-(3-{4-[1-(4-tetrahydropyranyl-phenyl)-1-methyl-ethyl]- phenoxymethyl}-benzyloxy)-benzonitrile (Example 5)are metered into a solution of 45.5 kg (272mol) of lithium-bis(trimethylsilyl-Jamide in 266 kg of THF at about 0°C.
The resulting suspension is stirred for about 10 h at about 25°C. The solid then goes into solution. After the addition of 68 litres of toluene the reaction mixture is cooled to —10° to 0°C and at this temperature 30.8 kg (284mol) of ethyl chloroformate are added to the reaction vessel. Once the reaction has finished completely 24.3 kg of 37% hydrochloric acid (diluted with 50 litres of water) are metered in and about 20 min later the aqueous lower phase is separated off. Crystallisation of the intended : -- ~~ --- product is initiated by the subsequent addition of 106 litres of acetone, 48litresof ~~ methylisobutylketone and 24.3 kg of 37% hydrochloric acid. 123 kg (87%) of ethyl {[4-(3-{4-[1-(4-hydroxy-phenyl)-1-methyl-ethyl]}- phenoxymethyl}-benzyloxy)-phenyi}-imino-methyl}-carbaminate hydrochloride are obtained after centrifuging, washing with acetone and drying in vacuo.
Melting point: 170-175°C.
Example 7. Ethyl {{4-(3-{4-[1-(4-hydroxy-phenyl)-1-methyl-ethyl]-phenoxymethyl}- benzyloxy)-phenyl]-imino-methyl}-carbaminate: 466 litres of acetone and 142 kg of ethyl {{4-(3-{4-[1-(4-hydroxy-phenyl)-1-methyl- ethyi]-phenoxymethyl}-benzyloxy)-phenyl]-imino-methyl}-carbaminate hydrochloride (Example 6) are added to a solution of 109 kg of trisodium citrate dihydrate at 20°C.
After one hour's stirring the crystalline product is separated off by filtration, washed with water to remove any salts, washed again with about 100 litres of acetone and finally dried in vacuo. 116 kg (90%) of ethyl {[4-(3-{4-[1-(4-hydroxy-phenyl)-1-methyl-ethyl]- phenoxymethyl}-benzyloxy)-phenyl]-imino-methyl}-carbaminate are obtained.

Claims (7)

  1. ® 17 Patent Claims 1) Process for preparing compounds of formula (I) 0 e oR? LINN a TO 0) wherein R1 denotes a group selected from among methyl, ethyl, propyl, cyclopentyl, cyclohexyl, phenyl, benzyl and -C(Me2)phenyl, each of which may be mono-, di- or trisubstituted by hydroxy; R2 denotes a group selected from among methyl, ethyl, propyl and benzyl, ~~~ -=-=-- — characterised in that a compound of formula (Il) Cs CN EJ, Ir “ye (1) wherein R1" denotes a group selected from among methyl, ethyl, propyl, cyclopentyl, cyclohexyl, phenyl, benzyl and -C(Me»)phenyl, each of which may be mono-, di- or trisubstituted by a group -O-PG, the group -O-PG denoting a protected hydroxyl function selected from among methoxymethyloxy, 2- methoxyethoxymethyloxy, 1-ethoxyethyloxy, 2-tetrahydropyranyloxy , 1-butoxyethyloxy, tert.-butyloxy, benzyloxy and 4-methoxybenzyloxy, is first reacted in an ethereal or aromatic solvent with an alkali metal hexaalkyldisilazane and is then treated with a compound of formula (I)
    R2-0-COX' (Il) wherein R2 js as hereinbefore defined and X' denotes chlorine, bromine or -O-R2,
    ® 18 after working up using an acid of formula HY a compound of formula (IV) 0] HN OR? RE or NH x HY Ac (IV) and/or the tautomeric form thereof, wherein the groups R1 and RZ are as hereinbefore defined and Y denotes any desired acid group, is isolated and from this the compound of formuia (1) is liberated.
  2. 2) Process according to claim 1, wherein R1 denotes a group selected from among phenyl, benzyl and -C(Me)phenyl, each of which may be mono- or disubstituted by hydroxy; RZ denotes a group selected from among ethyl, propyl and benzyl, : © ~ characterised in that a compound of formula (iy ~~ So wherein RT" denotes a group selected from among phenyl, benzyl and -C(Meo)phenyl, each of which may be mono- or disubstituted by a group -O-PG, the group -O-PG denoting a protected hydroxy! function selected from among methoxymethyloxy, 2-methoxyethoxymethyloxy, 1-ethoxyethyloxy, 2-tetrahydropyranyloxy , 1-butoxyethyloxy, tert.-butyloxy, benzyloxy and 4-methoxybenzyloxy, is first reacted in an ethereal or aromatic solvent with an alkali metal hexaalkyldisilazane and then treated with a compound of formula (il) R2-0-COX' (Ill) wherein RZ is as hereinbefore defined and X' denotes chlorine, bromine or -O-R2, after working up with aqueous hydrochloric acid a compound of formula (IVA) 0 HN OR? El jon x HCI es (IVA) wherein the groups R1 and R2 are as hereinbefore defined is isolated and from this the compound of formula (1) is liberated.
    ® 19
  3. 3) Process according to claim 1 or 2, wherein R1 denotes -C(Meo)phenyl which may optionally be monosubstituted by hydroxy and R2 denotes ethyl, characterised in that a compound of general formula (11) wherein R1" denotes -C(Mep)phenyl, which may optionally be monosubstituted by a group -O-PG, the group -O-PG denoting a protected hydroxyl function selected from among methoxymethyloxy, 2-tetrahydropyranyloxy , 1-butoxyethyloxy, tert.-butyloxy, benzyloxy and 4-methoxybenzyloxy, is first reacted in an ethereal or aromatic solvent with an alkali metal hexaalkyldisilazane and then treated with a compound of formula (lll) R2-0-COX' (ll) wherein =~ --~RZ - is as hereinbefore definedand ~~ ~~ Co I ST X' denotes chlorine, bromine or -O-R2, after working up using an acid of formula HX a compound of formula (IV) is isolated wherein the groups Y, R1 and RZ are as hereinbefore defined and from this the compound of formula (1) is liberated.
  4. 4) Process for preparing a compound of formula | according to one of claims 1 to 3, characterised by the following steps:
    (e) reacting C,,-alkyl 3-halomethylbenzoates with 4-hydroxybenzonitrile in the manner of a Wilkinson ether synthesis; fH) reductively converting alkyl 3-(4-cyano-phenoxy)benzoates of formula (Vil) SNe SAN (Vi) wherein R’ denotes C,4-alkyl, into a compound of forma (V) RO - V)
    ® 2 wherein X denotes hydroxy; (g) optionally treating the compound of formula (V) wherein X denotes hydroxy with a halogenating reagent or a sulphonic acid chloride; (h) reacting the compound of formula (V) wherein X denotes hydroxy, chlorine, bromine, mesylate, triflate or tosylate, with a phenol derivative of formula (VI) “LL wherein R1" has the meanings given in claims 1 to 4; optionally in the form of the corresponding sodium or potassium phenoxides, under basic reaction conditions, in a polar organic solvent; (i) converting the resulting compound of formula (ll) into the compound of formula (I) using the method according to claims 1 to 3.
  5. 5). Intermediate products of formula (IVA) and/or the tautomeric form thereof hi HN” “OR? (IVA) wherein the groups R1 and RZ may have the meanings given in claims 1, 2 or
    3.
  6. 6) Intermediate products of general formula (V), Io “ye (V) wherein X denotes hydroxy, chlorine, bromine, mesylate, triflate or tosylate.
  7. 7) Intermediate products according to claim 6, wherein X denotes hydroxy or chlorine.
    PUNT ® 2 8) Intermediate products of general formula (Vii) SAO: (VIH) wherein R' denotes C1-4-alkyl. 9) Use of the intermediate products of general formula (IV) according to claim 5 for preparing a compound of formula (I) according to claim 1. 10) Use of the intermediate products of general formula (V) according to claim 6 or 7 for preparing a compound of formula (I) according to claim 1. 11) Use of the intermediate products of general formula (Vil) according to claim 8
    ~~... for preparing a compound of formula (I) according to claim 1. Co
ZA200205746A 2000-01-12 2002-07-18 Method for producing aryl-iminomethyl-carbamic acid esters. ZA200205746B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10000907A DE10000907A1 (en) 2000-01-12 2000-01-12 Process for the preparation of aryl-iminomethyl-carbamic acid esters

Publications (1)

Publication Number Publication Date
ZA200205746B true ZA200205746B (en) 2004-04-08

Family

ID=7627236

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200205746A ZA200205746B (en) 2000-01-12 2002-07-18 Method for producing aryl-iminomethyl-carbamic acid esters.

Country Status (31)

Country Link
EP (1) EP1250318B1 (en)
JP (1) JP2003523328A (en)
KR (1) KR100681726B1 (en)
CN (2) CN1255378C (en)
AR (1) AR027208A1 (en)
AT (1) ATE311360T1 (en)
AU (1) AU2846401A (en)
BG (1) BG106916A (en)
BR (1) BR0107551A (en)
CA (1) CA2399598C (en)
CO (1) CO5261523A1 (en)
CZ (1) CZ296784B6 (en)
DE (2) DE10000907A1 (en)
EA (1) EA005006B1 (en)
EE (1) EE04960B1 (en)
ES (1) ES2253388T3 (en)
HK (1) HK1051851A1 (en)
HU (1) HUP0300348A3 (en)
IL (1) IL150621A (en)
MX (1) MXPA02006846A (en)
MY (1) MY117435A (en)
NO (1) NO20023348D0 (en)
NZ (1) NZ520713A (en)
PL (1) PL356607A1 (en)
SK (1) SK286709B6 (en)
TW (1) TWI228119B (en)
UA (1) UA71664C2 (en)
UY (1) UY26524A1 (en)
WO (1) WO2001051457A2 (en)
YU (1) YU52602A (en)
ZA (1) ZA200205746B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5262623B2 (en) * 2008-11-26 2013-08-14 株式会社豊田中央研究所 Method for producing sulfonamide compound

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0518818A3 (en) * 1991-06-11 1993-04-28 Ciba-Geigy Ag Arylethers, their manufacture and use as medicament
JPH06279389A (en) * 1993-03-30 1994-10-04 Terumo Corp Amidinophenyl ether derivative
DE4424713A1 (en) * 1994-07-13 1996-01-18 Boehringer Ingelheim Kg Substituted benzamidines, their preparation and their use as pharmaceutical substances
ATE403644T1 (en) * 1999-12-06 2008-08-15 Ajinomoto Kk AMIDINOPHENYL PYRUFURIC ACID DERIVATIVE

Also Published As

Publication number Publication date
TWI228119B (en) 2005-02-21
CA2399598C (en) 2008-09-02
CN1187322C (en) 2005-02-02
HK1051851A1 (en) 2003-08-22
WO2001051457A2 (en) 2001-07-19
NZ520713A (en) 2004-07-30
NO20023348L (en) 2002-07-11
CA2399598A1 (en) 2001-07-19
CO5261523A1 (en) 2003-03-31
CN1255378C (en) 2006-05-10
SK286709B6 (en) 2009-03-05
CN1541999A (en) 2004-11-03
HUP0300348A2 (en) 2003-06-28
PL356607A1 (en) 2004-06-28
SK10042002A3 (en) 2002-11-06
ATE311360T1 (en) 2005-12-15
CZ20022283A3 (en) 2002-10-16
BR0107551A (en) 2002-10-08
BG106916A (en) 2003-04-30
KR20020073166A (en) 2002-09-19
MXPA02006846A (en) 2002-12-13
KR100681726B1 (en) 2007-02-15
EA200200741A1 (en) 2002-12-26
EA005006B1 (en) 2004-10-28
UA71664C2 (en) 2004-12-15
AR027208A1 (en) 2003-03-19
DE50108237D1 (en) 2006-01-05
DE10000907A1 (en) 2001-07-19
WO2001051457A3 (en) 2002-01-17
UY26524A1 (en) 2001-07-31
MY117435A (en) 2004-06-30
JP2003523328A (en) 2003-08-05
IL150621A (en) 2007-06-17
EE200200392A (en) 2003-10-15
AU2846401A (en) 2001-07-24
EE04960B1 (en) 2008-02-15
IL150621A0 (en) 2003-02-12
ES2253388T3 (en) 2006-06-01
HUP0300348A3 (en) 2005-01-28
CZ296784B6 (en) 2006-06-14
EP1250318B1 (en) 2005-11-30
NO20023348D0 (en) 2002-07-11
CN1395557A (en) 2003-02-05
EP1250318A2 (en) 2002-10-23
YU52602A (en) 2006-01-16

Similar Documents

Publication Publication Date Title
US7417149B2 (en) Process for the preparation of Montelukast
US7091364B2 (en) Process for the industrial synthesis of tetraesters of 5-[bis(carboxymethyl)amino]-3-carboxymethyl-4-cyano-2-thiophenecarboxylic acid, and application to the synthesis of bivalent salts of ranelic acid and their hydrates
EP3802515B1 (en) Process for the preparation of apalutamide
US20030087930A1 (en) Process for preparing 2-(4-chlorobenzolamino)-3[ (1h)-quinolinon-4-yl] propionic acid
CN104356129A (en) Novel method for producing tiotropium salts
US20030236437A1 (en) Process to prepare sulfonamides
US20010011142A1 (en) Processes and intermediates useful to make antifolates
US20040014983A1 (en) Method for preparing benzisoxazole methane sulfonyl chloride and its amidation to form zonisamide
US6417382B2 (en) Process for preparing aryl-iminomethyl-carbamino acid esters
CA2399598C (en) Process for preparing aryl-iminomethyl-carbamino acid esters
HU229135B1 (en) Benzofurane derivatives
CZ433298A3 (en) Methyl ester derivatives of 4-iodine-2-[n-alkyl-aminocarbonyl)-aminosulfonyl]benzoic acid, process of their preparation and their use for preparation of herbicidal sulfonyl ureas
US6121476A (en) Process for preparing dithiocarbonimide derivatives
HU184758B (en) Process for producing 5-mercapto-1,2,3-triazole derivatives
EP0274353B1 (en) Process for the preparation of benzoin sulfonates
JP3926402B2 (en) Process for producing carbamoyloxyacetic acid and intermediates useful in the process
US20040063953A1 (en) Method of producing N-alkoxycarbonylpiperidine derivative, new compound as raw material therefor, and method of producing the compound
JPH11171855A (en) Production of optically active n-substituted alpha-amino-gamma-halogenobutyric acid ester
JP2001316350A (en) Carbonic acid ester compound of hydroxyguanidine and method for producing the same
PL190620B1 (en) Derivatives of amino phenylketone and method of obtaining them
JPH11209354A (en) Production of 3,5-dimethylisoxazole-4-sulfonyl chloride
JP2003183251A (en) Method for producing aryl compound